Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Clinical trial NCT03639246 · COMPLETED
Trial details
- NCT number
- NCT03639246
- Sponsor
- Aravive, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-06
- Primary completion
- 2021-01-08
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.